Inhibition of T cell proliferation by macrophage tryptophan catabolism

Journal of Experimental Medicine

Volumn 189, Issue 9, 1999, Pages 1363-1372

  Munn, David H ^a   Shafizadeh, Ebrahim ^a   Attwood, John T ^a   Bondarev, Igor ^a   Pashine, Achal ^a   Mellor, Andrew L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Indoleamine 2,3 dioxygenase; Macrophage; Macrophage colony stimulating factor; T cells; Tryptophan

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT GAMMA INTERFERON; TRYPTOPHAN;

AMINO ACID METABOLISM; ARTICLE; CELL CYCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

CELL CYCLE; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA; DNA; G1 PHASE; GENE EXPRESSION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPHOCYTE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; T-LYMPHOCYTES; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 0033519278     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.9.1363     Document Type: Article

References (54)

1. Fazekas de St. Groth, B. 1998. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today. 19:448-454.
2. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
3. Munn, D.H., and E. Armstrong. 1993. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by interferon γ. Cancer Res. 53:2603-2613.
4. Munn, D.H., J. Pressey, A.C. Beall, R. Hudes, and M.R. Alderson. 1996. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages: a potential mechanism of antigen-specific peripheral lymphocyte deletion. J. Immunol. 156:523-532.
5. Shimizu, T., S. Nomiyama, F. Hirata, and O. Hayaishi. 1978. Indoleamine 2,3-dioxygenase: purification and some properties. J. Biol. Chem. 253:4700-4706.
6. Carlin, J.M., E.C. Borden, P.M. Sondel, and G.I. Byrne. 1989. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J. Leukoc. Biol. 45: 29-34.
7. Werner, E.R., B. Bitterlich, D. Fuchs, A. Hausen, G. Reibnegger, G. Szabo, M.P. Dierich, and H. Wachter. 1987. Human macrophages degrade tryptophan upon induction by interferon-γ. Life Sci. 41:273-280.
8. Taylor, M.W., and G. Feng. 1991. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5:2516-2522.
9. Pfefferkorn, E.R. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA. 81: 908-912.
10. Gupta, S.L., J.M. Carlin, P. Pyati, W. Dai, E.R. Pfefferkorn, and M.J. Murphy. 1994. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62:2277-2284.
11. Daubener, W., C. Mackenzie, and U. Hadding. 1995. Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones. Immunol. 86: 79-84.
12. Daubener, W., C. Remscheid, S. Nockemann, K. Pilz, S. Seghrouchni, C. Mackenzie, and U. Hadding. 1996. Antiparasitic effector mechanisms in human brain tumor cells: role of interferon-γ and tumor necrosis factor-α. Eur. J. Immunol. 26:487-492.
13. Nagineni, C.N., K. Pardhasaradhi, M.C. Martins, B. Detrick, and J.J. Hooks. 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:4188-4196.
14. Aune, T.M., and S.L. Pogue. 1989. Inhibition of tumor cell growth by interferon-γ is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J. Clin. Invest. 84:863-875.
15. Munn, D.H., M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown, and A.L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281:1191-1193.
16. Cady, S.G., and M. Sono. 1991. 1-methyl-D,L-tryptophan, β-(3-benzofuranyl)-D,L-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-D,L-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291:326-333.
17. Southan, M.D., R.J. Truscott, J.F. Jamie, L. Pelosi, M.J. Walker, H. Maeda, Y. Iwamoto, and S. Tone. 1996. Structural requirements of the competitive binding site of recombinant human indoleamine 2,3-dioxygenase. Med. Chem. Res. 1996:343-352.
18. Moriya, T., K. Hagio, and N. Yoneda. 1975. A facile synthesis of 6-chloro-D-tryptophan. Bull. Chem. Soc. Japan. 48: 2217-2218.
19. Munn, D.H., and N.K. Cheung. 1987. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Cancer Res. 47:6600-6605.
20. Sono, M., T. Taniguchi, Y. Watanabe, and O. Hayaishi. 1980. Indoleamine 2,3-dioxygenase: equilibrium studies of the tryptophan binding to the ferric, ferrous, and co-bound enzymes J. Biol. Chem. 255:1339-1345.
21. Bloxam, D.L., and W.H. Warren. 1974. Error in the determination of tryptophan by method of Denckla and Dewey. A revised procedure. Anal. Biochem. 60:621-625.
22. Yamamoto, S., and O. Hayaishi. 1967. Tryptophan pyrrolase of rabbit intestine: D- and L-tryptophan-cleaving enzyme or enzymes. J. Biol. Chem. 242:5260-5266.
23. Dai, W., and S. Gupta. 1990. Molecular cloning, sequencing and expression of human interferon-γ-inducible indoleamine 2,3-dioxygenase cDNA. Biochem. Biophys. Res. Commun. 168: 1-8.
24. + monocyte subset with phenotypic similarity to primate natural killer cells. Blood. 88:1215-1224.
25. Koide, Y., and A. Yoshida. 1994. The signal transduction mechanism responsible for gamma interferon-induced indoleamine 2,3-dioxygenase gene expression. Infect. Immun. 62:948-955.
26. Dai, W., and S.L. Gupta. 1990. Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-γ. J. Biol. Chem. 265:19871-19877.
27. Chon, S.Y., H.H. Hassanain, and S.L. Gupta. 1996. Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-γ-inducible expression of human indoleamine 2,3-dioxygenase gene. J. Biol. Chem. 271:17247-17252.
28. Stout, R.D., and J. Suttles. 1996. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today. 17:487-492.
29. Crabtree, G.R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science. 243:355-361.
30. Medawar, P.B. 1953. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7:320-328.
31. Kamimura, S., K. Eguchi, M. Yonezawa, and K. Sekiba. 1991. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta. Med. Okayama. 45:135-139.
32. Yoshida, R., T. Nukiwa, Y. Watanabe, M. Fujiwara, F. Hirata, and O. Hayaishi. 1980. Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice. Arch. Biochem. Biophys. 203:343-351.
33. Moffett, J., M. Espey, and M. Namboodiri. 1994. Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system. Cell Tissue Res. 278: 461-469.
34. Espey, M., Y. Tang, H. Morse, J. Moffett, and M. Namboodiri. 1996. Localization of quinolinic acid in the murine AIDS model of retrovirus-induced immunodeficiency: implications for neurotoxicity and dendritic cell immunopathogenesis. AIDS. 10:151-158.
35. Espey, M., J. Moffett, and M. Namboodiri. 1995. Temporal and spatial changes of quinolinic acid immunoreactivity in the immune system of lipopolysaccharide-stimulated mice. J. Leukoc. Biol. 57:199-206.
36. Yoshida, R., Y. Urade, K. Nakata, Y. Watanabe, and O. Hayashi. 1981. Specific induction of indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide in the mouse lung. Arch. Biochem. Biophys. 212:629-637.
37. Malina, H.Z., and X.D. Martin. 1996. Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye. Graefe's Arch. Clin. Exp. Ophthalmol. 234:457-462.
38. Casciari, J.J., S.V. Sotirchos, and R.M. Sutherland. 1988. Glucose diffusivity in multicellular tumor spheroids. Cancer Res. 48:3905-3909.
39. Li, C.K. 1982. The glucose distribution in 9L rat brain multicell tumor spheroids and its effect on cell necrosis. Cancer. 50: 2066-2073.
40. Fleckner, J., P.M. Martensen, A.B. Tolstrup, N.O. Kjeldgaard, and J. Justesen. 1995. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cycokines in cell lines. Cytokine. 7:70-77.
41. Smith, C.B., G.E. Deibler, N. Eng, K. Schmidt, and L. Sokoloff. 1988. Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation. Proc. Natl. Acad. Sci. USA. 85: 9341-9345.
42. Dauphinais, C., and W. Waithe. 1977. PHA stimulation of human lymphocytes during amino acid deprivation: protein, RNA, and DNA synthesis. J. Cell. Physiol. 91:357-368.
43. Woolley, P.V., R.L. Dion, and V.H. Bono. 1974. Effects of tryptophan deprivation on L1210 cells in culture. Cancer Res. 34:1010-1014.
44. Brunner, M. 1973. Regulation of DNA synthesis by amino acid limitation. Cancer Res. 33:29-32.
45. Tobey, R., and K. Ley. 1971. Isoleucine-mediated regulation of genome replication in various mammalian cell lines. Cancer Res. 31:46-51.
46. Cherwinski, H.M., R.G. Cohn, P. Cheung, D.J. Webster, Y.-Z. Xu, J.P. Caulfield, J.M. Young, G. Nakano, and J.T. Ransom. 1995. The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis. J. Pharmacol. Exp. Ther. 275:1043-1049.
47. Terada, N., K. Takase, P. Papst, A.C. Nairn, and E.W. Gelfand. 1995. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes. J. Immunol. 155:3418-3426.
48. Laliberte, J., A. Yee, Y. Xiong, and B.S. Mitchell. 1998. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood. 91:2896-2904.
49. DeSilva, D.R., K.B. Urdahl, and M.K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261-3267.
50. Bird, J.J., D.R. Brown, A.C. Mullen, N.H. Moskowitz, M.A. Mahowald, J.R. Sider, T.F. Gajewski, C.R. Wang, and S.L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:229-237.
51. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161:5338-5346.
52. Babitzke, P. 1997. Regulation of tryptophan biosynthesis: trp-ing the TRAP or how Bacillus subtilis reinvented the wheel. Molec. Microbiol. 26:1-9.
53. Knox, W.E., and A.H. Mehler. 1951. The adaptive increase of the tryptophan peroxidase-oxidase system of liver. Science. 113:237-238.
54. Schwartz, R.H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1-8.